Research scientists and clinicians are invited to submit manuscripts for publication to Journal of Maternal-Fetal & Neonatal Medicine:
Gian Carlo Di Renzo, MD, PhD
Professor and Chairman
Dept. of Ob/Gyn and Centre for Perinatal
and Reproductive Medicine
Santa Maria della Misericordia University Hospital
06132 San Sisto - Perugia - ITALY
tel. +39 075 5783829
tel. +39 075 5783231
fax +39 075 5783829
direnzo@unipg.it
Professor Dev Maulik
Journal of Maternal-Fetal & Neonatal Medicine
UMKC School of Medicine
2411 Holmes Street
Room M1-103B
Kansas City, MO 64108, USA
Tel: 816-235-1788
Fax: 816-235-6579
Email Address: journalm@umkc.edu
Editorial policy: The Journal will consider original material for publication relevant to the entire field of maternal-fetal and neonatal medicine, from laboratory research to clinical reports. All material is subject to peer review. Manuscripts in the fields of Neonatology and Maternal-fetal medicine should be submitted to Professor Gian Carlo Di Renzo or Professor Dev Maulik.
Articles will be published in the following groups:
Original Articles: The maximum length is 4000-6000 words, including headings, 200-word abstract, tables and figures and up to 30 references.
Short Reports: These should be of original laboratory or clinical contributions, 1500-2000 words, including a 100-word abstract and up to 10 references.
Letters to the Editor: These are short reports of case studies that impact and enhance clinical practice or diagnostic understanding. They should not include an abstract, nor exceed 1500 words and 15 references. Up to one table and one figure may be included.
Correspondence: Correspondence may offer criticism of published material in an objective, constructive and educational manner. Within these limits, Correspondence may be provocative and inducive of further debate. They may also discuss matters of general interest. The material for such can be taken from any source of information so long as it pertains to the general field of Maternal-Fetal Medicine, Newborn Medicine, Perinatal Genetics, and Perinatal Ethics in the broadest sense. Correspondence must be double-spaced throughout. They will be reviewed by the appropriate editor and will be subject to editing and possible abridgement. If accepted, a copy will be sent to the author(s) of the original article referred to in the Correspondence, giving the author(s) the opportunity to provide a rebuttal with new material considered for publication with the Correspondence.
Opinions and Hypotheses: These should be 400-600 words in length with one figure or table and a maximum of five references.
Review articles: The Journal will publish occasional review articles. These papers should examine published research on topics relevant to maternal-fetal medicine. The review article should provide a critical analysis of the available information, should lead to a rational conclusion, and highlight areas of future investigation. The length of these articles should be approximately 3000 words with no more than 30 references.
Education and Debate Articles: These are usually commissioned of maximum 2000 words, but reports on all aspects of medicine and health are welcomed. They will be peer-reviewed, and should contain an unstructured abstract of no more than 150 words.
Peer review: All articles are reviewed by two or more authorities to determine validity, significance, and originality of contents and conclusions. Authors will usually be advised as soon as possible whether their paper is accepted, requires revision for acceptance, or is rejected. The reviewers will be selected by the Editors.
Copyright: It is a condition of publication that authors vest or license copyright in their articles, including abstracts, in Informa UK Ltd or the named Society, Association, body or person that holds the copyright. This enables us to ensure full copyright protection and to disseminate the article, and the journal, to the widest possible readership in print and electronic formats as appropriate. All material should conform to the uniform requirements for manuscripts submitted to biomedical journals (Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med 1997;126:36-47). Authors submitting reports of randomized clinical trials should ensure that their report conforms with the CONSORT Statement (http://www.consort-statement.org; The Revised CONSORT Statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94). Authors will normally be entitled to publish any part of their paper elsewhere provided permission is requested and the usual acknowledgements are given. The assignment of the copyright will not affect subsisting patent rights or arrangements relating to them. Illustrations, tables or quotations from other publications are already copyrighted and can be reproduced only with written permission from the copyright owner. Written permission to use these should accompany the manuscript.
Presentation: Manuscripts should be typed, double spaced on A4 size paper. Papers should be structured into headed sections as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, Acknowledgements, and References. Each section should begin on a new sheet and be identified with the shoulder heading. Other subsection headings within the main headings may be used but should be limited. The first page should include: title, first and last name of the authors and their affiliations, short title (no more than 20 letters), key words (5-8), and the address for correspondence.
Letters to the Editor and Correspondence:
- Follow general formatting instructions above
- Title page must include "Letter to the Editor" or "Correspondence"
- Total length should not exceed 1,500 words
- No abstract, key words, or headings apart from "References"
- No acknowledgments
- A maximum of 15 references can be provided
- Maximum of one table and one figure (can be composed of a number of figures, e.g. part a & b) (Only Letters to the Editor)
Submission of manuscripts: All submissions should be made online at Journal of Maternal-Fetal & Neonatal Medicine's Manuscript Central site. New users should first create an account. Once a user is logged onto the site submissions should be made via the Author Centre.
The manuscript should clearly designate one author as correspondent to whom proofs will also be sent, and the full postal address, telephone number, facsimile number and e-mail address of this individual should be given. Articles should be written in English. Authors whose native language is not English are requested to have their manuscript checked for linguistic correctness before submission.
Full completion of the "Add a Reviewer" section is required as this may well speed up the review process in cases where reviewers are difficult to locate or unavailable. Please add the contact details for 3 preferred reviewers. Please do not suggest anyone from the same department as any of the authors.
Abstract: An abstract not exceeding 200 words should state the aim of the study, the main findings, and how the results were interpreted. Abstracts for case reports should not exceed 50 words.
Instructions for preparing structured abstracts
Structured abstracts should be no more than 200 words and consist of four paragraphs under the headings:
| Objective | A precise statement of the primary objectives of the study, including the primary focus (e.g. diagnosis, prognosis, prevention) and information concerning the specific population, test, or outcome being discussed. |
| Methods | How the study was performed, including details of clinical and/or technical procedures. |
| Results | The salient results of the study. |
| Conclusions | The conclusions and their clinical application; the need for new studies may be suggested. Equal emphasis should be given to positive and negative findings of equal scientific merit. |
Style: Define abbreviations when they first occur in the manuscript and from there on use only the abbreviation. When many unusual abbreviations are used, list them alphabetically with their definitions on a separate page. Whenever standardized abbreviations are available, use those; create new abbreviations only if absolutely unavoidable.
Use generic names for drugs. If identification of a brand name is wanted, insert it in parentheses together with the manufacturer's name and address after the first mention of the generic name, noting trademark (TM) or registered (®) if applicable.
Scientific measurements should be given in SI units, except for blood pressure, which should be expressed in mmHg.
Literature cited: References should follow the CBE Citation & Sequence format. CBE notes that writers should name all authors listed on the article when there are 2 to 10 authors. When there are more than 10 authors, only the first 10 are listed. Only works actually cited in the text should be included in the references. Indicate in the text with Arabic numbers inside square brackets. Spelling in the reference list should follow the original. References should then be listed in numerical order at the end of the article. Examples are provided as follows:
Journal article: [1] Steiner U, Klein J, Eiser E, Budkowski A, Fetters LJ. Complete wetting from polymer mixtures. Science 1992;258:1122-1129.
Book chapter: [2] Kuret JA, Murad F. Adenohypophyseal hormones and related substances. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon; 1990. pp 1334-1360.
Conference proceedings: [3] Irvin AD, Cunningham MP, Young As, editors. Advances in the control of Theileriosis. International Conference held at the International Laboratory for Research on Animal Dieseases; 1981Feb 9-13; Nairobi. Boston: Martinu Nijhoff Publishers; 1981.427p.
Dissertation or Thesis: [4] Mangie ED. A comparative study of the perceptions of illness in New Kingdom Egypt and Mesopotamia of the early first millennium [dissertation]. Akron (OH): University of Akron; 1991. 160 p. Available from: University Microfilms, Ann Arbor MI; AAG9203425.
Journal article on internet: [5] Loker WM. ''Campesinos'' and the crisis of modernization in Latin America. Jour of Pol Ecol [serial online] 1996; 3(1). Available: http://www.library.arizona.edu/ej/jpe/ volume_3/ascii-lokeriso.txt via the INTERNET. Accessed 1996 Aug 11.
Webpage: [6] British Medical Journal [Internet]. Stanford, CA: Stanford Univ; 2004 July 10 - [cited 2004 Aug 12]; Available from http://bmj.bmjjournals.com/
Internet databases: [7] Prevention News Update Database [Internet]. Rockville (MD): Centers for Disease Control and Prevention (US), National Prevention Information Network. 1988 Jun - [cited 2001 Apr 12]. Available from http://www.cdcnpin.org/db/public/dnmain.htm
Further examples and information can be found in the CBE style manual Scientific Style and Format, sixth edition.
Acknowledgments: The scientific and material contributions of others to the work should be acknowledged. Any grant supports should be listed and permission for reproduction of published material should be acknowledged.
Illustrations: All illustrations (including photographs, graphs and diagrams) should be referred to as Figures and their position indicated in the text (e.g., Figure 3). Each should be submitted on a separate sheet of paper, numbered on the back with Figure number (Arabic numerals) and the title of the paper. The captions of all figures should be submitted on a separate sheet, should include keys to symbols, and should make interpretation possible without reference to the text. Figures should ideally be professionally drawn and designed with the format of the journal in mind and should be capable of reduction.
Colour figures: Any figure submitted as a colour original will appear in colour in the journal's online edition free of charge and can be downloaded. Paper copy colour reproduction will only be considered on condition that authors contribute to the associated costs. Charges are: 
500/US$1030 for the first colour page and 250/US$515 for each colour page after per article. (Colour costs will be waived for invited Review Articles).
Tables: Tables should be submitted on separate sheets, numbered in Roman numerals, and their position indicated in the text (e.g., Table I). Each table should have a short, self-explanatory title. Vertical rules should not be used to separate columns. Units should appear in parentheses in the column heading but not in the body of the table. Any explanatory notes should be given as a footnote at the bottom of the table.
Proofs: Proofs will be sent by email to the author nominated for correspondence. Proofs are supplied for checking and making essential typographical corrections, not for general revision or alteration. Proofs must be returned (by mail or fax) within 48 hours of receipt.
Offprints and Reprints: Offprints and reprints of articles published in this journal can be purchased once the article has been published online. Corresponding authors will receive free online access to their article through our website. Reprints of articles published in this journal can be purchased through Rightslink® when proofs are received. Copies of the Journal can be purchased at the authors' preferential rate of 15.00/$25.00 per copy.
Declaration of interest: It is the policy of all Informa Healthcare to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/index.html#conflict).
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organisation with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers' bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.
All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and, where available, within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.
If no conflict is declared, the following statement will be attached to all articles:
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgements on conclusions drawn.
NIH Public Access Policy: In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded-research results may benefit future scientific and medical research. Because we value the current and future contributions our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare's position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:
- Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12-month embargo period;
- “funded work” shall be defined as the final, peer-reviewed manuscript that is accepted by the Editor in Chief of the journal. This manuscript must not be altered by Publisher's copyediting and typesetting services; and
- this embargo period begins the day the work is published online on our website.
Authority and responsibility The intellectual content of the paper is the responsibility of the authors. The Editor and the Publisher accept no responsibility for opinions and statements of authors. While every effort will be made by the Editor and Publisher to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequences of wrong information. The authors agree to keep the Editor and Publisher fully and effectually indemnified against any liability or claims that may arise out of the publication of inaccurate and/or misleading data.
Recommend
Mark
Alert
Link
Print
